Vanguard Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $711M | Sell |
|
|||||
|
2025
Q1 | $1.14B | Sell |
|
|||||
|
2024
Q4 | $510M | Buy |
|
|||||
|
2024
Q3 | $463M | Buy |
|
|||||
|
2024
Q2 | $310M | Sell |
|
|||||
|
2024
Q1 | $241M | Buy |
|
|||||
|
2023
Q4 | $310M | Buy |
|
|||||
|
2023
Q3 | $253M | Sell |
|
|||||
|
2023
Q2 | $207M | Sell |
|
|||||
|
2023
Q1 | $226M | Buy |
|
|||||
|
2022
Q4 | $210M | Buy |
|
|||||
|
2022
Q3 | $265M | Buy |
|
|||||
|
2022
Q2 | $235M | Sell |
|
|||||
|
2022
Q1 | $235M | Sell |
|
|||||
|
2021
Q4 | $214M | Sell |
|
|||||
|
2021
Q3 | $234M | Sell |
|
|||||
|
2021
Q2 | $264M | Sell |
|
|||||
|
2021
Q1 | $295M | Buy |
|
|||||
|
2020
Q4 | $314M | Buy |
|
|||||
|
2020
Q3 | $204M | Buy |
|
|||||
|
2020
Q2 | $189M | Buy |
|
|||||
|
2020
Q1 | $132M | Buy |
|
|||||
|
2019
Q4 | $132M | Buy |
|
|||||
|
2019
Q3 | $154M | Sell |
|
|||||
|
2019
Q2 | $122M | Buy |
|
|||||
|
2019
Q1 | $128M | Buy |
|
|||||
|
2018
Q4 | $144M | Buy |
|
|||||
|
2018
Q3 | $145M | Buy |
|
|||||
|
2018
Q2 | $162M | Buy |
|
|||||
|
2018
Q1 | $144M | Sell |
|
|||||
|
2017
Q4 | $169M | Buy |
|
|||||
|
2017
Q3 | $120M | Buy |
|
|||||
|
2017
Q2 | $52.4M | Buy |
|
|||||
|
2017
Q1 | $41.1M | Buy |
|
|||||
|
2016
Q4 | $24.6M | Buy |
|
|||||
|
2016
Q3 | $20M | Buy |
|
|||||
|
2016
Q2 | $16.3M | Buy |
|
|||||
|
2016
Q1 | $13M | Buy |
|
|||||
|
2015
Q4 | $13.7M | Buy |
|
|||||
|
2015
Q3 | $10.2M | Buy |
|
|||||
|
2015
Q2 | $15.8M | Buy |
|
|||||
|
2015
Q1 | $12.6M | Buy |
|
|||||
|
2014
Q4 | $6.61M | Buy |
|
|||||
|
2014
Q3 | $5.78M | Buy |
|
|||||
|
2014
Q2 | $6.02M | Buy |
|
|||||
|
2014
Q1 | $9.28M | Buy |
|
|||||
|
2013
Q4 | $6.14M | Sell |
|
|||||
|
2013
Q3 | $3.18M | Buy |
|
|||||
|
2013
Q2 | $3.43M | Buy |
|